Evidence map›Paper›PMID 37560253›Full record

ArticleClinical, cosmetic and investigational dermatology2023

Requirements for Brazilian Outpatient Centers of Excellence in Hidradenitis Suppurativa: Consensus Co-Creative Study.

Ericles Andrei Bellei, Miriam Emi Makinodan Shirozaki, Ana Lia Pradella Puglia, André Vicente Esteves de Carvalho, Barbara Riquena, Camilla Carlini Vallilo, Danilo de Barros, Erika Yumi Tamashiro, Gabriela Cintra, Gleison Vieira Duarte and 7 more

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ericles Andrei BelleiDepartment of Data, Digital, and Innovation, Novartis, São Paulo, Brazil.ORCID 0000-0002-6020-6356
Miriam Emi Makinodan ShirozakiDepartment of Data, Digital, and Innovation, Novartis, São Paulo, Brazil.
Ana Lia Pradella PugliaImmunology Franchise, Novartis, São Paulo, Brazil.ORCID 0000-0002-6410-7152
André Vicente Esteves de CarvalhoDermatology, Hospital Moinhos de Ventos de Porto Alegre, Porto Alegre, Brazil.
Barbara RiquenaImmunology Franchise, Novartis, São Paulo, Brazil.
Camilla Carlini ValliloImmunology Franchise, Novartis, São Paulo, Brazil.
Danilo de BarrosDermatology Service, Hospital Irmandade Santa Casa de Curitiba, Curitiba, Brazil.
Erika Yumi TamashiroImmunology Franchise, Novartis, São Paulo, Brazil.
Gabriela CintraImmunology Franchise, Novartis, São Paulo, Brazil.
Gleison Vieira DuarteDermatology, Instituto Bahiano de Imunoterapia (IBIS), Salvador, Brazil.ORCID 0000-0003-4160-5447
Maria Cecília da Matta Rivitti-MachadoHospital das Clínicas da Faculdade de Medicina, University of São Paulo (USP), São Paulo, Brazil.ORCID 0000-0003-2910-7330
Renata Ferreira MagalhãesSchool of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil.
Ricardo Figueiredo do NascimentoImmunology Franchise, Novartis, São Paulo, Brazil.
Roberto TunalaDepartment of Medical Affairs, Novartis, São Paulo, Brazil.
Roberto da SilvaDepartment of Dermatology, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
Wagner Guimarães Galvão CesarDermatology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Felipe Garutti ThiesImmunology Franchise, Novartis, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic skin condition. Its complexity and impact on patients highlight the need for multidisciplinary care that can address the physical, psychological, and social aspects. Centers of excellence can ideally provide the necessary infrastructure, resources, and expertise to effectively treat HS. However, there are still no consolidated models of centers of excellence in HS, and establishing their foundations is an intricate research challenge. Purposely, design and co-creation as innovation techniques are helpful approaches to this type of research. Methods: In this study, we conducted a co-creation with consensus among HS specialists to propose the criteria and requirements to establish outpatient centers of excellence of HS in Brazil. We followed a linear process with mixed methods in 6 stages. Results: The process resulted in 10 categories for establishing outpatient centers, including their respective requirements, rationale, and classification. The categories include onboarding and welcoming; infrastructure and procedures; infusion therapy; flows and referrals; staffing; disease management; metrics during diagnosis; metrics during treatment; awareness and advocacy; research and education. Discussion: The idealized outpatient centers can play a role in the complete multidisciplinary treatment for HS and advancing the science of healthcare services by providing a focus for research, training, and translation of findings into practice.

Indexed as

centers of excellenceco-designcommunity-based participatory researchconsensushealthcare innovationhealth services researchhidradenitis suppurativapatient-centered care

Identifiers

PMID37560253
PMCPMC10408663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.